PROSPECTS FOR THE PHYTOPREPARATIONS USE IN PARASITIC DISEASES

Abstract

Today, 89% of all parasitic diseases are caused by helminthiasis. The annual morbidityof helminthiasis in Ukraine is 1333 cases per 100 thousand population. Their influenceleads to the development of multiavitaminosis with decreased appetite, body weight andresistance to adverse factors and metabolic disorders. Therefore, the issues of effectiveprevention and treatment are extremely relevant.Objective - to conduct a marketing analysis of the range of antiparasitic phytodrugsavailable on the Ukrainian pharmaceutical market and to determine the prospects fortheir further use in medicine.Material and methods. The analysis of the range of drugs, dietary supplements andmedicinal plant raw materials with anthelmintic action available on the pharmaceuticalmarket of Ukraine was conductedResults. 102 trade names in various dosage forms were identified, according to theanalysis of the range of drugs, dietary supplements and medicinal plant raw materialswith anthelmintic action available on the pharmaceutical market of Ukraine. It has beenfound that the range of drugs is mainly represented only by biologically active additives(97.06%). It should be noted that among the drugs there are both one-component dietarysupplements (18.63%) and combined (81.37%). The ratio of shares in the production ofantiparasitic drugs is approximately the same, domestic producers - 48.04% and foreignmanufacturers - 51.96%.Therefore, taking into account the topicality of the parasitic diseases problem, it isadvisable to use phytodrugs because of the action complexity at the expense of thebiologically active substances of plants, the lack of toxicity in contradistinction tosynthetic antiparasitic drugs.Conclusions. The represented phytodrugs and dietary supplements can be used asadditional means for pharmacotherapy improvement of the worm infestations, as well asfor recurrence prevention.